| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2092022 | HLA-F | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 6 | - |
PV=1 FDR=1 FC=0.004 |
|
| 2092023 | HLA-F | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 6 | - |
PV=0.851 FDR=1 FC=0.004 |
|
| 2092024 | HLA-F | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 6 | - |
PV=1 FDR=1 FC=0.001 |
|
| 2092025 | HLA-F | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 6 | - |
PV=0.564 FDR=1 FC=0.007 |
